Found: 33
Select item for more details and to access through your institution.
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort.
- Published in:
- NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-018-0069-x
- By:
- Publication type:
- Article
Levetiracetam-responsive belly dancer's syndrome in a case of progressive supranuclear palsy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.
- Published in:
- Current Neurology & Neuroscience Reports, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1007/s11910-019-0918-y
- By:
- Publication type:
- Article
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 6922, doi. 10.3390/ijms23136922
- By:
- Publication type:
- Article
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4958, doi. 10.3390/ijms22094958
- By:
- Publication type:
- Article
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4440, doi. 10.3390/ijms22094440
- By:
- Publication type:
- Article
Levodopa-responsive breathing discomfort in Parkinson’s disease patients.
- Published in:
- Journal of Neural Transmission, 2018, v. 125, n. 7, p. 1033, doi. 10.1007/s00702-018-1890-4
- By:
- Publication type:
- Article
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers.
- Published in:
- Biomarker Insights, 2020, v. 15, p. 1, doi. 10.1177/1177271920964077
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 9, p. 5136, doi. 10.1007/s00415-022-11187-8
- By:
- Publication type:
- Article
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00509-w
- By:
- Publication type:
- Article
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 8, p. 3791, doi. 10.1007/s10072-024-07462-3
- By:
- Publication type:
- Article
Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 10, p. 4309, doi. 10.1007/s10072-021-05313-z
- By:
- Publication type:
- Article
Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1015, doi. 10.3390/diagnostics10121015
- By:
- Publication type:
- Article
Changes of olfactory tract in Parkinson's disease: a DTI tractography study.
- Published in:
- Neuroradiology, 2021, v. 63, n. 2, p. 235, doi. 10.1007/s00234-020-02551-4
- By:
- Publication type:
- Article
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 2, p. 335, doi. 10.3390/biom10020335
- By:
- Publication type:
- Article
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders.
- Published in:
- Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.647783
- By:
- Publication type:
- Article
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00689-0
- By:
- Publication type:
- Article
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes.
- Published in:
- Movement Disorders, 2023, v. 38, n. 4, p. 682, doi. 10.1002/mds.29336
- By:
- Publication type:
- Article
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.
- Published in:
- Movement Disorders, 2022, v. 37, n. 4, p. 669, doi. 10.1002/mds.28941
- By:
- Publication type:
- Article
An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders.
- Published in:
- Behavioural Neurology, 2022, p. 1, doi. 10.1155/2022/3972173
- By:
- Publication type:
- Article
Safety and efficacy of concomitant treatment with non‐vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study.
- Published in:
- Epilepsia (Series 4), 2024, v. 65, n. 8, p. e141, doi. 10.1111/epi.18039
- By:
- Publication type:
- Article
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.
- Published in:
- Amino Acids, 2021, v. 53, n. 3, p. 435, doi. 10.1007/s00726-021-02943-7
- By:
- Publication type:
- Article
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62604-z
- By:
- Publication type:
- Article
Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2453, doi. 10.1002/alz.13687
- By:
- Publication type:
- Article
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2444, doi. 10.1002/alz.13658
- By:
- Publication type:
- Article
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with mild cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076323
- By:
- Publication type:
- Article
Automatic assessment of classical Alzheimer's disease biomarkers in paired cerebrospinal fluid and plasma samples.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074761
- By:
- Publication type:
- Article
Synucleinopathy in Alzheimer's disease: role of the alpha‐synuclein seed amplification assays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075159
- By:
- Publication type:
- Article
Cerebrospinal fluid synaptic biomarkers in AT(N)‐based subgroups of Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072253
- By:
- Publication type:
- Article
Subtle cognitive deficits assessed by means of CANTAB in a cohort of subjects with CSF AD profile.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.068924
- By:
- Publication type:
- Article
A panel of novel astrocytic and synaptic biomarkers in serum and CSF for the differential diagnosis of frontotemporal dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051338
- By:
- Publication type:
- Article